Drug delays type 1 diabetes onset

Drug delays type 1 diabetes onset

Drug delays type 1 diabetes onsetAt a Glance In a clinical trial, the drug teplizumab delayed type 1 diabetes onset and improved insulin production in high-risk individuals. The results support the use of the drug for delaying or preventing type 1 diabetes. Results from a clinical trial published in 2019 showed that a two-week course of the drug teplizumab delayed the onset of type 1 diabetes by two years and halved the rate of diabetes diagnoses. “If approved for use, this will be the first drug to delay or prevent type 1 diabetes,” Herold notes. But even delaying type 1 diabetes onset can make a big difference in the lives of those at high risk.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!